Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 257 of 1,261
  1. US 11364297

    Photosensitizing antibody-fluorophore conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  2. US 11364235

    Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic

    Actinium Phamaceuticals, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  3. US 11364211

    Methods for selecting phosphatase selective and non-selective phosphatase inhibitors

    United Kingdom Research and Innovation · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  4. US 11364197

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  5. US 11366121

    Specific GNAI:GIV interaction screening assays, methods and compositions

    The Regents of the University of California · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  6. US 11364202

    Solid forms of cannabidiol and uses thereof

    Artelo Biosciences, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  7. US 11365413

    Inhibition of poly(A) binding protein and the treatment of pain

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  8. US 11365394

    Enhanced immune effector cells and use thereof

    Fate Therapeutics, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  9. US 11365416

    Modulators of EZH2 expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  10. US 11365293

    Xylan-based dual network nanocomposite hydrogel, preparation method thereof and use therefor

    South China University of Technology · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  11. US 11365280

    Photocurable resin composition

    KURARAY NORITAKE DENTAL INC. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  12. US 11365262

    Cell

    AUTOLUS LIMITED · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  13. US 11365250

    Compositions and methods for cancer therapy

    The Board of Regents of the University of Texas System · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  14. US 11365246

    Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases

    CHEMOMAB LTD. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  15. US 11365230

    Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof

    IMMUNE DESIGN CORP. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  16. US 11365205

    Imidazolidin-2-one compounds as PRMT5 modulators

    Aurigene Discovery Technologies Limited · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  17. US 11365195

    Atypical inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  18. US 11365221

    Compositions and methods for treating autoimmune and inflammatory disorders

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  19. US 11364308

    Adeno-associated virus variant capsids and methods of use thereof

    4D MOLECULAR THERAPEUTICS INC. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  20. US 11364300

    C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

    Revolution Medicines, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  21. US 11364298

    Photosensitizing antibody-fluorophore conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  22. US 11365180

    Resolution method for axis chiral enantiomers of lesinurad

    CHINA RESOURCES SAIKE PHARMACEUTICAL CO., LTD. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  23. US 11364304

    Crosslinked micellar spherical nucleic acids

    Northwestern University · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  24. US 11364309

    Neuronal enhancers

    UNIVERSITY OF CONNECTICUT · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.